CAS RN: 932372-01-5

Asapiprant

Product Availability

Choose a grade to view its available package options.

11 package records9 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250915 100mg Out of stock Inquiry
Batchno.20250615 10mg In stock Shanghai Inquiry
Batchno.20260302 1mg In stock Shanghai Inquiry
Batchno.20260615 25mg In stock Shanghai Inquiry
Batchno.20260414 50mg Out of stock Inquiry
Batchno.20250111 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250330 10mg In stock Inquiry
Batchno.20250504 1mg In stock Inquiry
Batchno.20260323 25mg In stock Inquiry
Batchno.20260409 50mg In stock Inquiry
Batchno.20251220 5mg In stock Inquiry
  • Product code: starshine_CAS932372-01-5
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

932372-01-5 / 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]acetic acid

Standard CAS: 932372-01-5 Multi CAS: No

Basic Information

CAS
932372-01-5
Multi CAS
No
Molecular Formula
C24H27N3O7S
Molecular Weight
501.600000
Exact Mass
501.156971
InChI
InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29)
InChIKey
ZMZNWNTZRWXTJU-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
35
Aromatic heavy atom count
17
Fraction Csp3
0.33
Rotatable bonds
9
H-bond acceptors
8
H-bond donors
1
Molar refractivity
128.25
TPSA
122.41

LogP / Solubility

WLOGP
3.1
MLOGP
2.77
XLogP3
3.1
Consensus LogP
2.99
Log S (ESOL)
-4.67
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.91
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.58
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.58

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us